This site is intended for healthcare professionals
News

Phase III GEMINI 1 and 2 clinical trials of AGN 190584 meet primary endpoints in presbyopia.- Allergan/AbbVie

Read time: 1 mins
Last updated:29th Oct 2020
Published:29th Oct 2020
Condition: Presbyopia
Type: drug
Register free for full access to medthority.com